Alkermes plc
 
公司簡況
財務
派息紀錄
盈利預測
股權變動
ETF簡況
 
 
 
公司概覽
業務類別 Drug Manufacturers - Specialty & Generic
業務概覽 Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
公司地址 1 Burlington Road, Connaught House, Dublin, IRL, D04 C5Y6
電話號碼 +353 17728000
傳真號碼 --
公司網頁 https://www.alkermes.com
員工數量 2050
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Richard F. Pops Chairman of the Board and Chief Executive Officer 美元 1.21M 25/02/2026
Mr. Joshua Reed Senior Vice President and Chief Financial Officer -- 25/02/2026
Mr. Samuel J. Parisi Interim Principal Accounting Officer; Vice President, Finance of Alkermes, Inc. -- 25/02/2026
Mr. Iain M. Brown Senior Vice President, Chief Financial Officer and Principal Accounting Officer 美元 256.72K 05/02/2024
Mr. David Joseph Gaffin Executive Vice President, Chief Legal Officer, Secretary and Chief Compliance Officer 美元 664.56K 07/04/2025
Dr. Craig C. Hopkinson, M.D. Executive Vice President, Research and Development and Chief Medical Officer 美元 742.56K 07/04/2025
Mr. Christian Todd Nichols Senior Vice President and Chief Commercial Officer 美元 596.96K 07/04/2025
Mr. Blair C. Jackson Executive Vice President and Chief Operating Officer 美元 715.00K 25/02/2026
 
董事會成員
董事會 職務 更新日期
Mr. Brian P. Mckeon Independent Director 25/02/2026
Dr. Cato T. Laurencin,M.D.,PhD Independent Director 25/02/2026
Mr. Richard F. Pops Chairman of the Board and Chief Executive Officer 25/02/2026
Mr. Frank Anders Wilson Lead Independent Director 25/02/2026
Mr. Shane M. Cooke Independent Director; Chairman of the Board of Alkermes Pharma Ireland Limited 25/02/2026
Ms. Nancy S. Lurker Independent Director 25/02/2026
Dr. Nancy L. Snyderman, F.A.C.S.,M.D. Independent Director 25/02/2026
Dr. Richard Brian Gaynor, M.D. Independent Director 25/02/2026
Dr. Christopher I. Wright, M.D.,PhD Independent Director 25/02/2026
 
所屬ETF (更新日期: 07/03/2026 04:29)
代號 名稱 佔比% ▼ 持有日期
SCDSJPMorgan Fundamental Data Sci Sm Cor ETF0.001%27/02/2026
ACSGAmerican Century Small Cp Gr Insgts ETF0.001%28/02/2026
NSCSNuveen Small Cap Select ETF0.001%26/06/2025
GRPZInvesco S&P SmallCap 600 GARP ETF0.001%27/02/2026
PBSMInvesco PureBeta MSCI USA Small Cap ETF0.0005%31/05/2023
EBITHarbor AlphaEdge Small Cap Earners ETF0.0004%28/02/2026
BMEDiShares Health Innovation Active ETF0.0001%26/02/2026
AVIEAvantis Inflation Focused Equity ETF0.0001%28/02/2026
HDGProShares Hedge Replication0.0001%27/02/2026
CDEICalvert US Large-Cp Div, Eq AndIncETF0.0001%27/02/2026
GTPEGoldman Sachs MSCI Wld Priv Eq RtTrkrETF0.0001%27/02/2026
MMTMState Street® SPDR® S&P® 1500MomtTiltETF0.00004%27/02/2026
ABLSAbacus FCF Small Cap Leaders ETF<0.000001%03/09/2025
AVLCAvantis U.S. Large Cap Equity ETF<0.000001%18/09/2025
AVMVAvantis U.S. Mid Cap Value ETF<0.000001%27/09/2025
BTALAGF U.S. Market Neutral Anti-Beta<0.000001%01/12/2025
ESUMEventide US Market ETF<0.000001%31/07/2025
FEACFidelity Enhanced U.S. All-Cap Eq ETF<0.000001%25/02/2026
FSCSFirst Trust SMID Capital Strength ETF<0.000001%19/10/2025
FTLSFirst Trust Long/Short Equity ETF<0.000001%02/12/2025
  1    2    3    4    5    6   7    8  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.